A recent study conducted in Sweden found that GLP-1 agonists such as Ozempic and Wegovy may help reduce alcohol consumption and related harms in individuals diagnosed with alcohol use disorder.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
